bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
Amid the spread of COVID-19, testing for SARS-COV-2, the virus that causes it, is at the forefront of the battle. Patients rely on test results to confirm if they’ve acquired the coronavirus, and public health entities around globe rely on the data to learn how and where the virus is spreading.
Patients at the greatest risk for secondary infections, particularly infections that are resistant to first-line antibiotics, include people who are already vulnerable due to other conditions and diseases—like COVID-19. Because of that, antimicrobial resistance poses a significant additional threat, especially as healthcare systems become overburdened.
The World Health Organization (WHO) estimates that Tuberculosis (TB) caused 1.5 million deaths in 2018. It’s one of the top ten causes of death worldwide and the leading cause of death from a single infectious agent.
As COVID-19 continues to spread, misinformation has often been more contagious than the virus itself, and a lack of concrete information in some areas has compounded the problem.
Patients at the greatest risk for secondary infections, particularly infections...
With the COVID-19 pandemic having reached over 170 countries, and...